drugset / Trial / NCT00304785

Latanoprost Versus Fotil

NCT00304785

Phase 4 Completed 36 enrolled Pharmaceutical Research Network
RandomizedCrossoverDouble-blindTreatment

Summary

To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.

Timeline

Start
2005-05
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fotil Unknown
Subject Latanoprost Small molecule 0.005 %